Despite recommencement of TNF inhibitor during or after tuberculosis treatment, the tuberculosis were treated successfully in all patients as scheduled, and did not recur during follow-up [median 33.8 (IQR 20.8–66.7) months; early resumers 37.0 (20.8–67.4) and late resumers 33.6 (18.5–52.7)]. The gene discussed is TNF; the disease is tuberculosis.